• Wissam Chatila


The intensive care unit (ICU) is a special environment that often harbors a considerable number of highly resistant organisms. Critically ill patients are frequently exposed to broad-spectrum antibiotics and invasive procedures that make them more susceptible either to be colonized by exogenous organisms or to have overgrowth of resistant endogenous strains. As newer antimicrobials are introduced, many organisms have demonstrated the capability to develop resistance to these newer agents; thus, it is common to find intensivists facing the challenge of treating highly selected organisms while trying to minimize emergence of other antibiotic-resistant organisms.


Intensive Care Unit Respiratory Syncytial Virus Resistant Organism Herpes Simplex Virus Encephalitis Lipid Formulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Aoki FY. Principles of Antimicrobial Therapy and the Clinical Pharmacology of Antimicrobial Drugs. Principles of Critical Care, 2nd Ed. New York: McGraw-Hill, 1998.Google Scholar
  2. Hayden FG. Antiviral drugs (other than antiretrovirals). In: Mandell XX (ed) Principles and Practice in Infectious Diseases, 5th Ed. New York: Churchill Livingstone, 2000.Google Scholar
  3. Patel R. Antifungal agents. Part I. Amphotericin B preparations and flucytosine. Mayo Clin Proc 1998; 73: 1205–1225.PubMedCrossRefGoogle Scholar
  4. Terrell CL. Antifungal agents. Part II. The azoles. May Clin Proc 1999; 74: 78–100.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Wissam Chatila

There are no affiliations available

Personalised recommendations